These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 20881959)

  • 1. Update on new antivirals under development for the treatment of double-stranded DNA virus infections.
    Dropulic LK; Cohen JI
    Clin Pharmacol Ther; 2010 Nov; 88(5):610-9. PubMed ID: 20881959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro comparison of currently available and investigational antiviral agents against pathogenic human double-stranded DNA viruses: A systematic literature review.
    Chemaly RF; Hill JA; Voigt S; Peggs KS
    Antiviral Res; 2019 Mar; 163():50-58. PubMed ID: 30677427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PJA1 Coordinates with the SMC5/6 Complex To Restrict DNA Viruses and Episomal Genes in an Interferon-Independent Manner.
    Xu W; Ma C; Zhang Q; Zhao R; Hu D; Zhang X; Chen J; Liu F; Wu K; Liu Y; Wu J
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30185588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fifty Years in Search of Selective Antiviral Drugs.
    De Clercq E
    J Med Chem; 2019 Aug; 62(16):7322-7339. PubMed ID: 30939009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses.
    Florescu DF; Keck MA
    Expert Rev Anti Infect Ther; 2014 Oct; 12(10):1171-8. PubMed ID: 25120093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginkgolic acid inhibits fusion of enveloped viruses.
    Borenstein R; Hanson BA; Markosyan RM; Gallo ES; Narasipura SD; Bhutta M; Shechter O; Lurain NS; Cohen FS; Al-Harthi L; Nicholson DA
    Sci Rep; 2020 Mar; 10(1):4746. PubMed ID: 32179788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brincidofovir: understanding its unique profile and potential role against adenovirus and other viral infections.
    Alvarez-Cardona JJ; Whited LK; Chemaly RF
    Future Microbiol; 2020 Apr; 15():389-400. PubMed ID: 32166967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. R430: A potent inhibitor of DNA and RNA viruses.
    D'Aiuto L; McNulty J; Hartline C; Demers M; Kalkeri R; Wood J; McClain L; Chattopadhyay A; Zhi Y; Naciri J; Smith A; Yolken R; Chowdari K; Zepeda-Velazquez C; Dokuburra CB; Marques E; Ptak R; Kinchington P; Watkins S; Prichard M; Bloom D; Nimgaonkar V
    Sci Rep; 2018 Nov; 8(1):16662. PubMed ID: 30413769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbon nanotubes supported tyrosinase in the synthesis of lipophilic hydroxytyrosol and dihydrocaffeoyl catechols with antiviral activity against DNA and RNA viruses.
    Botta G; Bizzarri BM; Garozzo A; Timpanaro R; Bisignano B; Amatore D; Palamara AT; Nencioni L; Saladino R
    Bioorg Med Chem; 2015 Sep; 23(17):5345-51. PubMed ID: 26260341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acridones as antiviral agents: synthesis, chemical and biological properties.
    Sepúlveda CS; Fascio ML; García CC; D'Accorso NB; Damonte EB
    Curr Med Chem; 2013; 20(19):2402-14. PubMed ID: 23521684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
    Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
    J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of brincidofovir for the treatment of mixed dsDNA viral infection.
    Camargo JF; Morris MI; Abbo LM; Simkins J; Saneeymehri S; Alencar MC; Lekakis LJ; Komanduri KV
    J Clin Virol; 2016 Oct; 83():1-4. PubMed ID: 27513204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.
    De Clercq E
    Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease.
    Crute JJ; Grygon CA; Hargrave KD; Simoneau B; Faucher AM; Bolger G; Kibler P; Liuzzi M; Cordingley MG
    Nat Med; 2002 Apr; 8(4):386-91. PubMed ID: 11927945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral acyclic nucleoside phosphonates structure activity studies.
    Holý A
    Antiviral Res; 2006 Sep; 71(2-3):248-53. PubMed ID: 16857275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of topical and intralesional cidofovir.
    Zabawski EJ
    Dermatol Online J; 2000 Sep; 6(1):3. PubMed ID: 11328613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.
    De Clercq E
    Clin Microbiol Rev; 2003 Oct; 16(4):569-96. PubMed ID: 14557287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hamao Umezawa Memorial Award Lecture: "An Odyssey in the Viral Chemotherapy Field".
    De Clercq E
    Int J Antimicrob Agents; 2001 Oct; 18(4):309-28. PubMed ID: 11691563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA viral infections complicating lung transplantation.
    Clark NM; Lynch JP; Sayah D; Belperio JA; Fishbein MC; Weigt SS
    Semin Respir Crit Care Med; 2013 Jun; 34(3):380-404. PubMed ID: 23821512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging antiviral drugs.
    De Clercq E
    Expert Opin Emerg Drugs; 2008 Sep; 13(3):393-416. PubMed ID: 18764719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.